Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Nivolumab × Gastrointestinal × Clear all

Phase

Phase 2 116 Phase 1 65 Phase 1/2 56 Phase 3 19 Phase 2/3 7 Phase EARLY_PHASE1 4 Phase NA 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5 Thoracic 3 Dermatologic 3 Tumor-Agnostic 1 Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

Oxaliplatin 17 Capecitabine 16 Fluorouracil 12 Bevacizumab 12 Esomeprazole 9 Sorafenib 8 Propofol 7 Leucovorin 7 Irinotecan 7 Morphine 6 Folfox protocol 6 Bismuth 6 lenvatinib 5 Sevoflurane 5 S 1 (combination) 5 Radiofrequency Ablation 5 Amoxicillin 5 sodium glycididazole 4 gadolinium ethoxybenzyl DTPA 4 fish oil triglycerides 4 ferric carboxymaltose 4 Tetracycline 4 Ribavirin 4 HMPL-013 4 Gemcitabine 4 Control Groups 4 Cetuximab 4 Celecoxib 4 regorafenib 3 raltitrexed 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04707547 2021-01-13

RFA

Taipei Medical University WanFang Hospital

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡